Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 07:15 ET | Source: Alvotech

Alvotech announces planned CEO succession and leadership transition

- Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech...
January 06, 2026 07:15 ET | Source: Alvotech

Alvotech tilkynnir breytingar á yfirstjórn félagsins

Róbert Wessman heldur áfram sem starfandi stjórnarformaðurLisa Graver tekur við stöðu forstjóra Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag breytingar á yfirstjórn félagsins sem eru fram undan...
January 06, 2026 07:15 ET | Source: Alvotech

Alvotech announces planned CEO succession and leadership transition

Róbert Wessman to continue serving as Executive Chairman in full-time capacityLisa Graver appointed Chief Executive Officer REYKJAVIK, ICELAND (January 6, 2026) — Alvotech (NASDAQ: ALVO), a global...
January 06, 2026 07:05 ET | Source: Cartesian Therapeutics, Inc.

Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases,...
January 06, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
January 06, 2026 07:00 ET | Source: Abpro Corporation

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

FDA clearance enables initiation of Abpro’s first clinical-stage solid tumor program Clinical trial anticipated to commence in the first half of 2026 through Abpro’s global collaboration with...
January 06, 2026 07:00 ET | Source: Anfield Energy Inc.

Anfield Energy Achieves Transformative Milestones in 2025, Positioning Itself as a Key Player in America’s Nuclear Renaissance

VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”), a leading U.S.-focused uranium and vanadium...
January 06, 2026 07:00 ET | Source: Seres Therapeutics, Inc.

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Data demonstrate clinical translation of VOWST mechanisms of action in both first and multiply recurrent CDI patients Seres MbTx® platform provides high-resolution functional biological understanding...
January 06, 2026 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 44th Annual J.P. Morgan...
January 06, 2026 07:00 ET | Source: Plug Power, Inc.

Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference

SLINGERLANDS, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, announce its participation in...